"Saccharomycetales" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An order of fungi in the phylum Ascomycota that multiply by budding. They include the telomorphic ascomycetous yeasts which are found in a very wide range of habitats.
| Descriptor ID |
D004718
|
| MeSH Number(s) |
B01.300.107.795
|
| Concept/Terms |
Saccharomycetales- Saccharomycetales
- Saccharomycetale
- Yeast, Budding
- Endomycetales
- Endomycetale
- Budding Yeast
- Budding Yeasts
- Yeasts, Budding
|
Below are MeSH descriptors whose meaning is more general than "Saccharomycetales".
Below are MeSH descriptors whose meaning is more specific than "Saccharomycetales".
This graph shows the total number of publications written about "Saccharomycetales" by people in this website by year, and whether "Saccharomycetales" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 4 | 0 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 1 | 2 |
| 2021 | 2 | 2 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Saccharomycetales" by people in Profiles.
-
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Sci Immunol. 2021 07 15; 6(61).
-
COVID-19 and Candida duobushaemulonii superinfection: A case report. J Mycol Med. 2021 Sep; 31(3):101168.
-
Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain-based vaccine candidate, RBD219-N1C1. Appl Microbiol Biotechnol. 2021 May; 105(10):4153-4165.
-
N-Glycosylated Ganoderma lucidum immunomodulatory protein improved anti-inflammatory activity via inhibition of the p38 MAPK pathway. Food Funct. 2021 Apr 26; 12(8):3393-3404.
-
SARS-CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Hum Vaccin Immunother. 2021 08 03; 17(8):2356-2366.
-
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate. Biochim Biophys Acta Gen Subj. 2021 06; 1865(6):129893.
-
Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Pichia pastoris. Hum Vaccin Immunother. 2020 07 02; 16(7):1602-1610.
-
A case report of fungemia due to Kodamaea ohmeri. BMC Infect Dis. 2019 Jul 01; 19(1):570.
-
Genomic characterization of recurrent mold infections in thoracic transplant recipients. Transpl Infect Dis. 2018 Oct; 20(5):e12935.
-
Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention. Antimicrob Resist Infect Control. 2018; 7:45.